慢性心力衰竭患者循环溶性ST2的预后值
Yue Zhang1, Yunhong Liu1, Yuanxia Yang2
1Department of Clinical Laboratory, People's Hospital of Longhua, Shenzhen, China.
The Journal of international medical research
|January 13, 2026
概括
可溶性ST2 (sST2) 独立预测慢性心力衰竭患者的不良结果. 高的sST2水平与增加的死亡率和住院病例有关,这表明其预后价值.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 预测 预测 预测 预测 预测
背景情况:
- 慢性心力衰竭 (CHF) 带来了显著的死亡和发病风险.
- 确定可靠的预后生物标志物对于管理CHF患者至关重要.
- 溶性ST2 (sST2) 是一个潜在的生物标志物,涉及心脏重塑和炎症.
研究的目的:
- 在慢性心力衰竭患者中系统评估循环可溶性ST2 (sST2) 的独立预后值.
- 综合目前关于sST2与CHF死亡率和住院病例相关的证据.
主要方法:
- 进行了系统性审查和元分析,将研究与PROSPERO (CRD42023489018) 进行注册.
- 在PubMed,Embase和Web of Science进行了搜索,截至2024年9月1日.
- 使用纽卡斯尔-太华尺度评估研究质量;使用Review Manager软件分析数据.
主要成果:
- 分析包括17项研究,涉及慢性心力衰竭患者.
- 升高的sST2水平显著预测了所有原因的死亡率不佳 (HR1.03,p<0.00001).
- 高的sST2还预测了与心力衰竭相关的再入院 (HR 1.46,p<0.00001) 和心血管住院 (HR 1.50,p<0.00001).
结论:
- 循环中的溶性ST2作为慢性心力衰竭预后的独立预测剂.
- sST2生物标志物在预测死亡率和住院治疗方面表现强.
- 建议进行进一步的临床验证,以将sST2纳入常规的CHF管理.
更多相关视频
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
535
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
535
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
786
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
786
01:30Acute Coronary Syndrome III: Diagnostic Studies
209
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
215
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
215
01:29Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
476
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
476